pharma · Diphtheria · Diabetes Mellitus, Type 2
Sanofi Pasteur MSD
Sanofi Pasteur
Sanofi Pasteur is a pharma organization headquartered in LYON, FR. Primary therapeutic focus areas include Diphtheria, Diabetes Mellitus, Type 2, Japanese Encephalitis, Rabies, Hemophilia A. NovaPharmaNews links 83 clini
France, LYON HQ
363 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- France, LYON
- Employees
- 363
- Programs
- 83
- Drugs
- 66
- Patents
- 0
alglucosidase alfa
Approved · mab · Pompe Disease (Infantile-Onset)
alglucosidase alfa for Pompe Disease (Infantile-Onset) is a Approved program (mab) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Internal code AGLU07510
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Sanofi Pasteur
- Phase
- Approved
- Modality
- mab
- Indication
- Pompe Disease (Infantile-Onset)
- Status
- terminated
- Trials
- 1